<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Nucleophosmin1 (NPM1) gene located in chromosome 5q35 is affected by chromosomal translocation, mutation and deletion in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>NPM1 haploinsufficiency reportedly causes <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-like disorders in knockout mice </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we studied <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression in bone marrow (BM) samples from 36 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The NPM1 expression levels of <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein were not related to chromosome 5 abnormalities and were almost the same as those in <z:mpath ids='MPATH_458'>normal</z:mpath> BM and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>However, the protein levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cells with NPM1 mutations were slightly lower than in those without mutation </plain></SENT>
<SENT sid="5" pm="."><plain>Immunochemical studies showed no difference in the staining intensity and subcellular localisation between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> BM cells </plain></SENT>
<SENT sid="6" pm="."><plain>It was concluded that abnormal cytoplasmic localisation and/or significant reduction of NPM1 protein level rarely occurs in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The increase in the number of nuclear NPM1-positive cells may be related to the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>